Unlocking Tissue Resident Immunity For Solid Tumor Therapy

TCura Bioscience leverages novel discoveries in the field of T-Cell Memory to identify and validate new immunotherapy targets. We are committed to developing first-in-class therapies to transform the treatment of solid tumors.

Founding Team

  • Amir Ferry

    CO-FOUNDER & CEO

    PhD Candidate | Goldrath Lab | UC San Diego

  • Ananda Goldrath, Ph.D.

    CO-FOUNDER

    Executive VP & Director | the Allen Institute for Immunology

  • Miguel Reina-Campos, Ph.D.

    CO-FOUNDER

    Assistant Professor | La Jolla Institute for Immunology

Company News

  • BioLabs Investor Day

    March 2024

    TCura Bioscience was selected to pitch at the inaugural BioLabs Investor Day.

  • Platinum Program

    October 2023

    TCura Bioscience chosen as a Finalist for the Mission BioCapital Platinum Program

  • Company Founding

    August 2023

    TCura Bio founded to advance next-gen immuno-oncology medicines.

Scientific Advisors

  • Ananda Goldrath, Ph.D.

    Executive VP & Director | the Allen Institute for Immunology

  • Hongbo Chi, Ph.D.

    Endowed Chair, St Jude Children’s Research Hospital

  • Laura Mackay, Ph.D.

    Professor| Doherty Institute | University of Melbourne

Leave us a message.